Acetylcholinesterase (AChE) reactivators were developed for the treatment of organophosphate intoxication. Standard care involves the use of anticonvulsants (e.g., diazepam), parasympatolytics (e.g., atropine) and oximes that restore AChE activity. However, oximes also bind to the active site of AChE, simultaneously acting as reversible inhibitors. The goal of the present study is to determine how oxime structure influences the inhibition of human recombinant AChE (hrAChE). Therefore, 24 structurally different oximes were tested and the results compared to the previous eel AChE (EeAChE) experiments. Structural factors that were tested included the number of pyridinium rings, the length and structural features of the linker, and the number and position of the oxime group on the pyridinium ring.

Department of Toxicology Faculty of Military Health Sciences University of Defence Trebesska 1575 50001 Hradec Kralove Czech Republic

See more in PubMed

Wilson I.B., Ginsburg S. A powerful reactivator of alkylphosphate-inhibited acetylcholinesterase. Biochim. Biophys. Acta. 1955;18:168–170. PubMed

Wilson I.B., Ginsburg S. Reactivation of acetylcholinesterase inhibited by alkylphosphates. Arch. Biochem. Biophys. 1955;54:569–571. PubMed

Childs A.F., Davies D.R., Green A.L., Rutland J.P. The reactivation by oximes and hydroxamic acids of cholinesterase inhibited by organo-phosphorus compounds. Br. J. Pharmacol. Chemother. 1955;10:462–465. PubMed PMC

Bajgar J. Organophosphates/nerve agent poisoning: Mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem. 2004;38:151–216. PubMed

Macllwain C. Study proves Iraq used nerve gas. Nature. 1993;363:3. PubMed

Delfino R.T., Ribeiro T.S., Figueroa-Villar J.D. Organophosphorus compounds as chemical warfare agents: A review. J. Braz. Chem. Soc. 2009;20:407–428.

Nagao M., Takatori T., Matsuda Y., Nakajima M., Iwase H., Iwadate K. Definitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway. Toxicol. Appl. Pharmacol. 1997;144:198–203. PubMed

Jokanovic M., Stojiljkovic M.P. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning. Eur. J. Pharmacol. 2006;553:10–17. PubMed

Lorke D.E., Kalasz H., Petroianu G.A., Tekes K. Entry of oximes into the brain: A review. Curr. Med. Chem. 2008;15:743–753. PubMed

Karasova J.Z., Pohanka M., Musilek K., Zemek F., Kuca K. Passive diffusion of acetylcholinesterase oxime reactivators through the blood-brain barrier: Influence of molecular structure. Toxicol. in Vitro. 2010;24:1838–1844. PubMed

Palin R., Clark J.K., Cowley P., Muir A.W., Pow E., Prosser A.B., Taylor R., Zhang M.Q. Novel piperidinium and pyridinium agents as water-soluble acetylcholinesterase inhibitors for the reversal of neuromuscular blockade. Bioorg. Med. Chem. Lett. 2002;12:2569–2572. PubMed

Petrova I., Bielavsky J. An overview of the syntheses of cholinesterase reactivators from 1980 to 1992. Mil. Med. Sci. Lett. 2001;70:63–73.

Sepsova V., Karasova J., Zemek F., Bennion B.J., Kuca K. Oximes as inhibitors of acetylcholinesterase—A structure-activity relationship (SAR) study. Mil. Med. Sci. Lett. 2011;80:178–186. PubMed PMC

Oh K.A., Park N.J., Park N.S., Kuca K., Jun D., Jung Y.S. Reactivation of DFP- and paraoxon-inhibited acetylcholinesterases by pyridinium oximes. Chem. Biol. Interact. 2008;175:365–367. PubMed

Kuca K., Kassa J. A comparison of the ability of a new bispyridinium oxime-1-(4- hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. J. Enzyme Inhib. Med. Chem. 2003;18:529–535. PubMed

Musilek K., Dolezal M., Gunn-Moore F., Kuca K. Design, evaluation and structure-activity relationship studies of the AChE reactivators against organophosphorus pesticides. Med. Res. Rev. 2011;31:548–575. PubMed

Kassa J., Kuca K., Bartosova L., Kunesova G. The development of new structural analogues of oximes for the antidotal treatment of poisoning by nerve agents and the comparison of their reactivating and therapeutic efficacy with currently available oximes. Curr. Org. Chem. 2007;11:267–283.

Jin G.Y., He X.C., Zhang H.Y., Bai D.L. Synthesis of alkylene-linked dieters of (−)-huperzine A. Chin. Chem. Lett. 2002;13:23–26.

Kassa J., Jun D., Kuca K., Bajgar J. Comparison of reactivating and therapeutic efficacy of two salts of the oxime HI-6 against tabun, soman and cyclosarin in rats. Basic Clin. Pharmacol. Toxicol. 2007;101:328–332. PubMed

Musilek K., Holas O., Hambalek J., Kuca K., Jun D., Dohnal V., Dolezal M. Synthesis of bispyridinium compounds bearing propane linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetylcholinesterase. Lett. Org. Chem. 2006;3:831–835. PubMed

DeLano W.L. The PyMOL Molecular Graphics System, Version 1.3. Schrödinger, LLC; 2010.

Bolea I., Juarez-Jimenez J., de Los Rios C., Chioua M., Pouplana R., Luque F.J., Unzeta M., Marco-Contelles J., Samadi A. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease. J. Med. Chem. 2011;54:8251–8270. PubMed

Musilek K., Komloova M., Holas O., Hrabinova M., Pohanka M., Dohnal V., Nachon F., Dolezal M., Kuca K. Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage—Implications for early Myasthenia gravis treatment. Eur. J. Med. Chem. 2011;46:811–818. PubMed

Komloova M., Musilek K., Horova A., Holas O., Dohnal V., Gunn-Moore F., Kuca K. Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors-implications for early Myasthenia gravis treatment. Bioorg. Med. Chem. Lett. 2011;21:2505–2509. PubMed

Musilek K., Holas O., Kuca K., Jun D., Dohnal V., Opletalova V., Dolezal M. Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker—Synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett. 2007;17:3172–3176. PubMed

Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961;7:88–90. PubMed

Pohanka M., Hrabinova M., Kuca K. Diagnosis of intoxication by the organophosphate VX: Comparison between an electrochemical sensor and Ellman’s photometric method. Sensors. 2008;8:5229–5237. PubMed PMC

Sinko G., Calic M., Bosak A., Kovarik Z. Limitation of the Ellman method: Cholinesterase activity measurement in the presence of oximes. Anal. Biochem. 2007;370:223–227. PubMed

Duan J.X., Dixon S.L., Lowrie J.F., Sherman W. Analysis and comparison of 2D fingerprints: Insights into database screening performance using eight fingerprint methods. J. Mol. Graph. Model. 2010;29:157–170. PubMed

Trott O., Olson A.J. Software news and update autodock vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010;31:455–461. PubMed PMC

Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera—A visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605–1612. PubMed

Kryger G., Harel M., Giles K., Toker L., Velan B., Lazar A., Kronman C., Barak D., Ariel N., Shafferman A., et al. Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. Acta Crystallogr. D. 2000;56:1385–1394. PubMed

Harel M., Schalk I., Ehretsabatier L., Bouet F., Goeldner M., Hirth C., Axelsen P.H., Silman I., Sussman J.L. Quaternary ligand-binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc. Natl. Acad. Sci. USA. 1993;90:9031–9035. PubMed PMC

Bourne Y., Grassi J., Bougis P.E., Marchot P. Conformational flexibility of the acetylcholinesterase tetramer suggested by X-ray crystallography. J. Biol. Chem. 1999;274:30370–30376. PubMed

Carltonine-derived compounds for targeted butyrylcholinesterase inhibition

In Vitro Evaluation of Oxidative Stress Induced by Oxime Reactivators of Acetylcholinesterase in HepG2 Cells

Structure-Guided Design of N-Methylpropargylamino-Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer's Disease

Design and synthesis of novel tacrine-indole hybrids as potential multitarget-directed ligands for the treatment of Alzheimer's disease

Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-d-Aspartate Receptor Antagonists

Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors

Toxic Injury to Muscle Tissue of Rats Following Acute Oximes Exposure

Development of small bisquaternary cholinesterase inhibitors as drugs for pre-treatment of nerve agent poisonings

Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy

Oximes: inhibitors of human recombinant acetylcholinesterase. A structure-activity relationship (SAR) study